A dietary supplement is defined as a product taken by mouth containing a dietary ingredient intended to supplement the diet. Dietary ingredients include vitamins, minerals, herbs or other botanicals, and amino acids.
Select an Issue
Dietary Supplement Resource Library
Explore our list of resources to learn more about the dietary supplement category and how it is regulated by the U.S. Food and Drug Administration (FDA) and Federal Trade Commission (FTC).
The Dietary Supplements Access Act of 2023 is bipartisan legislation intended to give American consumers increased flexibility to best determine how to use their pre-tax dollars to stay healthy.
It’s a common misconception that the dietary supplements category is not regulated, when in fact it is regulated by multiple government agencies, with manufacturers and retailers also managing responsibility throughout the process.
The types of evidence used to monitor dietary supplement safety, including adverse event reports, emergency room visits and poison control center data.
The four leading trade associations representing the dietary supplement industry are concerned that some marketers of dietary supplements may be promoting them with claims of prevention or treatment of Coronavirus.
CHPA today applauds the U.S. Food and Drug Administration for enforcing existing provisions in the Federal Food, Drug, and Cosmetic Act by sending warning letters to 15 companies illegally marketing cannabidiol products.
CHPA submitted this citizen petition to address the definition of a dietary supplement under section 201(ff) of the Federal Food, Drug and Cosmetic Act and to request that FDA establishes a regulatory pathway to legally market dietary supplements containing CBD.
Today CHPA submitted a citizen petition to the U.S. Food and Drug Administration urging the agency to exercise its existing statutory authority to swiftly issue regulations that establish a clear pathway for manufacturers to lawfully market cannabidiol in dietary supplements.
This week, the four leading trade associations representing the U.S. dietary supplement industry joined forces to urge Congress to take action to ensure consumer safety and provide legal clarity in the CBD product marketplace.
Modernizing food and dietary supplement labels is in the best interest of consumers and industry alike. Supplement facts labels serve as a trusted source of information and provide a consistent way to comprehend nutrient content.
As many dietary supplement products are being marketed as containing cannabidiol (CBD), CHPA has an interest in this subject and we presented oral comments at FDA’s May 31, 2019, public hearing. These written comments supplement our oral remarks.
Herein, the Consumer Healthcare Products Association provides feedback on the Food and Drug Administration (FDA) request for comments on Responsible Innovation on Dietary Supplements.
CHPA supports efforts to encourage FDA to develop a legal path for CBD as a new dietary ingredient. Hemp oil is already an appropriate dietary ingredient.
